Literature DB >> 10440073

When a rose is a rose in speech but a tulip in writing.

A E Hillis1, B C Rapp, A Caramazza.   

Abstract

We report the pattern of performance on language tasks by a neurologically impaired patient, RCM, who makes semantic errors in writing to dictation and in written naming, but makes very few errors at all (and no semantic errors) in spoken naming, oral reading, or spontaneous speech. RCM also shows a significant effect of concreteness on spelling accuracy and other features of so-called "deep dysgraphia." However, it is shown that, unlike previously reported patients described as deep dysgraphic, RCM has intact semantic processing but impairment in accessing lexical-orthographic representations, at least for the items tested. These results demonstrate that the collection of features labelled as "deep dysgraphia" can arise from damage to different cognitive processes. Detailed analyses of RCM's performance across lexical tasks, at two different time periods of recovery, provide evidence that lexical orthographic representations can be either directly activated by lexical semantic representations, or activated by the interaction of lexical semantic and sublexical information from phonology-to-orthography conversion mechanisms.

Entities:  

Mesh:

Year:  1999        PMID: 10440073     DOI: 10.1016/s0010-9452(08)70804-9

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  13 in total

1.  A developmental fMRI study of reading and repetition reveals changes in phonological and visual mechanisms over age.

Authors:  Jessica A Church; Rebecca S Coalson; Heather M Lugar; Steven E Petersen; Bradley L Schlaggar
Journal:  Cereb Cortex       Date:  2008-01-31       Impact factor: 5.357

2.  Evaluating Spelling in Glioma Patients Undergoing Awake Surgery: a Systematic Review.

Authors:  Fleur van Ierschot; Roelien Bastiaanse; Gabriele Miceli
Journal:  Neuropsychol Rev       Date:  2018-12-21       Impact factor: 7.444

3.  A treatment sequence for phonological alexia/agraphia.

Authors:  Pélagie M Beeson; Kindle Rising; Esther S Kim; Steven Z Rapcsak
Journal:  J Speech Lang Hear Res       Date:  2010-04       Impact factor: 2.297

4.  Grey and white matter substrates of action naming.

Authors:  Yu Akinina; O Dragoy; M V Ivanova; E V Iskra; O A Soloukhina; A G Petryshevsky; O N Fedinа; A U Turken; V M Shklovsky; N F Dronkers
Journal:  Neuropsychologia       Date:  2019-05-23       Impact factor: 3.139

5.  Modality and morphology: what we write may not be what we say.

Authors:  Brenda Rapp; Simon Fischer-Baum; Michele Miozzo
Journal:  Psychol Sci       Date:  2015-04-29

6.  Patterns of dysgraphia in primary progressive aphasia compared to post-stroke aphasia.

Authors:  Andreia V Faria; Jenny Crinion; Kyrana Tsapkini; Melissa Newhart; Cameron Davis; Shannon Cooley; Susumu Mori; Argye E Hillis
Journal:  Behav Neurol       Date:  2013       Impact factor: 3.342

Review 7.  Neuroanatomical foundations of naming impairments across different neurologic conditions.

Authors:  Ezequiel Gleichgerrcht; Julius Fridriksson; Leonardo Bonilha
Journal:  Neurology       Date:  2015-06-26       Impact factor: 9.910

8.  Vocabulary acquisition in aphasia: Modality can matter.

Authors:  Leena Tuomiranta; Ann-Mari Grönroos; Nadine Martin; Matti Laine
Journal:  J Neurolinguistics       Date:  2014-11-01       Impact factor: 1.710

9.  Where (in the brain) do semantic errors come from?

Authors:  Lauren Cloutman; Rebecca Gottesman; Priyanka Chaudhry; Cameron Davis; Jonathan T Kleinman; Mikolaj Pawlak; Edward H Herskovits; Vijay Kannan; Andrew Lee; Melissa Newhart; Jennifer Heidler-Gary; Argye E Hillis
Journal:  Cortex       Date:  2008-11-12       Impact factor: 4.027

10.  Patterns of breakdown in spelling in primary progressive aphasia.

Authors:  Kathryn Sepelyak; Jennifer Crinion; John Molitoris; Zachary Epstein-Peterson; Maralyssa Bann; Cameron Davis; Melissa Newhart; Jennifer Heidler-Gary; Kyrana Tsapkini; Argye E Hillis
Journal:  Cortex       Date:  2009-12-22       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.